Roivant Sciences Ltd (ROIV)
11.84
-0.04
(-0.34%)
USD |
NASDAQ |
Dec 13, 16:00
11.72
-0.12
(-1.01%)
After-Hours: 20:00
Roivant Sciences Total Assets (Quarterly): 6.206B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Organon & Co | 12.75B |
| AstraZeneca PLC | 104.92B |
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 625.99M |
| Shareholders Equity (Quarterly) | 5.153B |
| Current Ratio | 10.43 |
| Net Debt Paydown Yield | 1.02% |